Abstract
Background
Thymoma patients with pleural dissemination are difficult to manage, and their treatment strategy remains undefined. This study aimed to investigate the clinicopathologic features of these patients, focusing on the association between the depth of pleural invasion and prognosis.
Methods
Between 2003 and 2019, the study identified 120 disseminated lesions in 20 thymoma patients. Seven patients had de novo stage IVa thymoma and 13 were recurrent cases. Extrapleural pneumonectomy was performed for 8 patients and debulking surgery for 12 patients. Invasion depth of pleural tumors was classified into two groups: when the disseminated tumors invaded the pleura beneath the elastic layer, the tumor was diagnosed as Da, and when the disseminated tumors invaded the pleura beyond the elastic layer, the tumor was diagnosed as Db.
Results
Of 120 nodules, 31 (26%), found in eight patients with recurrent malignancies, were classified as Db. The pathologic status of the surgical margin (PSM) was positive in eight patients, seven of whom had Db nodules. The 5-year overall survival (OS) rate was 100% in the Da group and 75% in the Db group (P = 0.02). The 5-year progression-free survival (PFS) rate was 66.7% in the Da group and 25% in the Db group (P = 0.02). Cox univariate analysis showed that PFS was significantly influenced by the depth of invasion (P = 0.04) and PSM (P = 0.03).
Conclusion
Depth of pleural invasion may influence survival outcomes for thymoma patients with pleural dissemination. The patients in this study with Da-disseminated nodules had an increased probability of a longer OS and PFS and tended to achieve negative PSM compared with the patients with Db.
Similar content being viewed by others
References
Detterbeck FC, Zeeshan A. Thymoma: current diagnosis and treatment. Chin Med J. 2013;126:2186–91.
Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.
Weissferdt A, Kalhor N, Bishop JA, et al. Thymoma: a clinicopathological correlation of 1470 cases. Hum Pathol. 2018;73:7–15.
Vladislav T, Jain RK, Alvarez R, et al. Extrathoracic metastasis of thymic origin: a review of 35 cases. Mod Pathol. 2012;25:370–7.
Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1320 patients from Japan. Ann Thorac Surg. 2003;76:878–85.
Brierley JD, Gospodarowicz MK, Wittekiind C. UICC, TNM Classification of Malignant Tumours. 8th edn. New York, NY: Wiley; 2017.
Yano M, Sasaki H, Yukiue H, et al. Thymoma with dissemination: efficacy of macroscopic total resection of disseminated nodules. World J Surg. 2009;33:1425–31.
Okuda K, Yano M, Yoshino I, et al. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan. Ann Thorac Surg. 2014;97:1743–9.
Moser B, Fadel E, Fabre D, et al. Surgical therapy of thymic tumours with pleural involvement: an ESTS thymic working group project. Eur J Cardiothorac Surg. 2017;52:346–55.
Liu HC, Chen YJ, Tzen CY, et al. Debulking surgery for advanced thymoma. Eur J Surg Oncol. 2006;32:1000–5.
Lucci M, Davini F, Ricciardi R, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg. 2009;137:1185–9.
Murakawa T, Karasaki T, Kitano K, et al. Invasive thymoma disseminated into the pleural cavity: mid-term results of surgical resection. Eur J Cardiothorac Surg. 2015;47:567–72.
Imanishi N, Nabe Y, Takenaka M, et al. Extended pleurectomy decortication for thymoma with pleural dissemination. Gen Thorac Cardiovasc Surg. 2019;67:814–7.
Miyahara R, Hasegawa S, Kono T, et al. Extended pleurectomy decortication for Masaoka stage IVa thymoma with massive pleural and pericardial dissemination. Gen Thorac Cardiovasc Surg. 2020;68:1569–72.
Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVa thymoma. Ann Thorac Surg. 2006;82:1234–9.
Huang J, Rizk NP, Travis WD, et al. Feasibility of multimodality therapy including extended resections in stage IVa thymoma. J Thorac Cardiovasc Surg. 2007;134:1477–83.
Ishikawa Y, Matsuguma H, Nakahara R, et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: the potential role of extrapleural pneumonectomy. Ann Thorac Surg. 2009;88:952–7.
Fabre D, Fadel E, Mussot S, et al. Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma. Eur J Cardiothorac Surg. 2011;39:133–8.
Nakamura S, Kawaguchi K, Fukui T, et al. Multimodality therapy for thymoma patients with pleural dissemination. Gen Thorac Cardiovasc Surg. 2019;67:524–9.
Travis WD, Brambilla E, Burke AP, et al. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart. IARC, Lyon, 2015.
Yokoi K. Revision of the general rule for surgical record of lung cancer (in Japanese). Jpn J Lung Cancer. 2012;52:68–71.
The Japan Lung Cancer Society. General Rule for Clinical and Pathological Record of Lung Cancer (in Japanese), 8th ed. Kanehara, Tokyo, 2017.
Huang J, Detterbeck FC, Wang Z, et al. Standard outcome measures for thymic malignancies. J Thorac Oncol. 2010;5:2017–23.
Tateo V, Manuzzi L, Parisi C, et al. An overview on molecular characterization of thymic tumors: old and new targets for clinical advances. Pharmaceuticals. 2021;14:316.
Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovascular Surg. 2005;130:160–5.
Butnor KJ, Beasley MB, Cagle PT, et al. Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. Arch Pathol Lab Med. 2009;133:1552–9.
Yoshida J, Nagai K, Asamura H, et al. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol. 2009;4:959–63.
Travis WD, Brambilla E, Rami-Porta R, et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol. 2008;3:1384–90.
Nagaishi C. Pulmonary Pleura: Functional Anatomy and Histology of the Lung. Chapter 6. Igaku Shoin, Tokyo, 1972, pp 254–61.
Dail DH, Hammer SP. Pulmonary Pathology. New York: Springer-Verlag Inc; 1988. p. 789–826.
Corrin B, Nicholson AG. Pathology of the Lungs E-Book: Expert Consult. Online and in print, Elsevier Health Sciences, Oxford, 2011.
Taube JM, Askin FB, Brock MV, et al. Impact of elastic staining on the staging of peripheral lung cancers. Am J Surg Pathol. 2007;31:953–6.
Kimura K, Kanzaki R, Kimura T, et al. Long-term outcomes after surgical resection for pleural dissemination of thymoma. Ann Surg Oncol. 2019;26:2073–80.
Acknowledgments
We thank Dr. Kota Ono (https://ono-biostat-consulting.com/), also an employee of AbbVie GK.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nakamura, S., Tateyama, H., Nakanishi, K. et al. Pleural Invasion Depth of Disseminated Nodules in Patients with Stage IVa or Recurrent Thymoma: Assessment, Curative Impact, and Surgical Outcomes. Ann Surg Oncol 29, 1829–1837 (2022). https://doi.org/10.1245/s10434-021-10888-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10888-0